Why are you reporting this TALK?
Anifrolumab reduces steroids in LTE
Leonard CalabreseVisit
vumedi.com
to learn moreJuly 2, 2024
10 hr
Channels
DiscoveryCardiologyCOVIDDermatologyEndocrinologyGastroenterologyHematologyHepatologyNephrologyNeurologyOncologyOphthalmologyEvery DayAMDDry Eye DiseaseEyeCan: A Canadian Lens on OphthalmologyVISIONS 2024ARVO 2024AAO 2023WIO 2022
Primary CarePulmonologyRheumatologyUrologyDescription
Anifrolumab reduces steroids in LTE